The Fontan-infective endocarditis paradox: should patients with a Fontan circulation be counselled for antibiotic prophylaxis?

Eur J Prev Cardiol. 2024 May 11;31(7):e47-e48. doi: 10.1093/eurjpc/zwad260.

Authors

Claudia Montanaro^{1

2}, Katherine Dahill¹, Alessandra Frigiola^{3

4}, Siobhan Boyle¹, Michael A Gatzoulis^{1

2}

Affiliations

¹ Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital Part of Guy's and St Thomas' NHS Foundation Trust, Sydney St, London, SW3 6NP, UK.
² National Heart & Lung Institute, Imperial College London, Exhibition Rd, London, SW7 2BX, UK.
³ Adult Congenital Heart Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁴ Cardiovascular Imaging Science, King's College, London, UK.

PMID: 37556721
DOI: 10.1093/eurjpc/zwad260

No abstract available

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antibiotic Prophylaxis*
Endocarditis / prevention & control
Endocarditis, Bacterial / diagnosis
Endocarditis, Bacterial / microbiology
Endocarditis, Bacterial / prevention & control
Fontan Procedure* / adverse effects
Heart Defects, Congenital / surgery
Humans
Risk Assessment
Risk Factors

Substances

Anti-Bacterial Agents